Significant Ownership of Datuk Dr. Doris Wong Sing Ee
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Datuk Dr. Doris Wong Sing Ee focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Datuk Dr. Doris Wong Sing Ee - Chief Executive Officer and Executive Director
- Manager location
- Wilayahpersekutuankuala Lumpur, Malaysia
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Datuk Dr. Doris Wong Sing Ee and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Datuk Dr. Doris Wong Sing Ee
Significant Ownership of Datuk Dr. Doris Wong Sing Ee
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 70% | $58,388,646 | 194,628,820 | Doris Wong Sing Ee | 26 Feb 2025 | ||
| BGMS | Bio Green Med Solution, Inc. | Common Stock, par value $0.0001 per share | 21% | $5,555,655 | 1,111,131 | Doris Wong Sing Ee | 12 Nov 2025 |
Schedules 13D/G Reported by Datuk Dr. Doris Wong Sing Ee:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.